We are a group of clinical and translational researchers - physicians, scientists, and trainees - dedicated to developing the most advanced particle and radiotherapy techniques to deliver the safest, most precise, and most effective treatments for children and adults with cancer.

Our group has 3 key areas of focus:
1. Particle Therapy: Proton therapy, proton reirradiation, mixed proton/photon treatments, electron therapy, total skin electrons, conformal proton FLASH, proton arc therapy
2. Novel Combined Modality Approaches: Radiotherapy combined with immunotherapy, bispecific agents, chimeric antigen receptor T-cell (CART) therapy, stem cell transplantation
3. Artificial Intelligence: AI for advanced treatment planning, improved plan quality, rapid initiation of treatment